-
Kintor partners with Fosun to market Covid-19 therapy in India and Africa
pharmaceutical-technology
July 15, 2021
Kintor Pharmaceutical has signed a licensing agreement with Shanghai Fosun Pharmaceutical Development to market its drug, proxalutamide, for Covid-19 in India and 28 African countries.
-
US claims it is unable to send COVID vaccines as India needs to review its legal provisions
expresspharma
July 15, 2021
We are ready to ship those vaccines expeditiously when we have a green light from the Government of India, said State Department Spokesperson Ned Price.
-
COVID-19 vaccine doses administered in India so far surpasses 39 crores: Health Ministry
expresspharma
July 15, 2021
Cumulatively, 11,78,70,724 people in the age group 18-44 years have received the first dose and 41,92,141 their second dose since the start of phase three of the vaccination drive.
-
Abbott launches Panbio COVID-19 Antigen Self-Test in India
expresspharma
July 14, 2021
The self-test features a minimally invasive nasal swab and delivers results in as early as15 minutes with no instrumentation.
-
Shortage of Sputnik V’s second dose to delay India’s full roll out, says Dr Reddy’s
expresspharma
July 14, 2021
Dr Reddy's had received about three million first doses by 1st June and about 360,000 doses of the second by early this month, the company and the Indian government have said.
-
India has huge resource material for research: Jitendra Singh
expresspharma
July 13, 2021
COVID-19 provides opportunity to work on strategic research outcomes which are specifically India-centric, said the Union Minister.
-
Sanofi, GSK get approval for Phase 3 COVID-19 vaccine trial in India
expresspharma
July 09, 2021
In a two-stage approach, the study will initially investigate the efficacy of a vaccine formulation targeting the original virus strain (D.614), while a second stage will evaluate a second formulation targeting the Beta variant (B.1.351).
-
RDIF and Morepen Laboratories announce test batch manufacturing of Sputnik V in India
expresspharma
July 07, 2021
The Russian Direct Investment Fund (RDIF) and Morepen Laboratories announced the production of the test batch of the Russian Sputnik V coronavirus vaccine in an exclusive facility in the state of Himachal Pradesh (HP).
-
Study finds rise in antibiotic misuse in India during COVID first wave
expresspharma
July 06, 2021
The researchers estimated that COVID-19 likely contributed to 216.4 million excess doses of antibiotics and 38 million more doses of azithromycin in adults from June 2020 through September 2020.
-
Impact of COVID-19 2.0 on Indian pharma industry is minimal: ICRA
expresspharma
July 05, 2021
In FY2022, ICRA sample set is estimated to witness Y-o-Y growth of 6-8 per cent in domestic market formulations, 5-7 per cent in US business and 8-10 per cent in European business.